STEPHEN DOMINEY: Open Payments
NPI 1831646041 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 12 payments from 8 companies in 2025. Trend: 2023 $681 · 2024 $268 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $121 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| GlaxoSmithKline, LLC. | 1 | $41 |
| Amgen Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: ACTHAR, FARXIGA, BENLYSTA, TAVNEOS, PREVYMIS, JYNARQUE, GIVLAARI.
Industry payments across GA — which companies pay providers there.
